CLINICAL_TRIALS
withdrawal
· 2018-04-25
Clinical Trial Update: A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting [Phase 3]
Summary
The document notes the withdrawal of a Phase 3 single-arm trial evaluating home administration of Lebrikizumab for asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 3 | Status: WITHDRAWN